BRAWN BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Brawn Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-4.69₹ -0.99
As on Nov 4, 2025, 4:01 PM IST
Brawn Biotech Price Performance
Today's LowToday's High
₹20.11₹20.11
₹20.11
52 Weeks' Low52 Weeks' High
₹15.46₹26.05
₹20.11
Open Price
₹20.11
Prev. Close
₹21.10
Volume
1
Over the last 5 years, the share price of Brawn Biotech has gained 0.11% CAGR. Over the past year, the corresponding return has been -10.86%.
Brawn Biotech’s current P/E of -5.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Brawn Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Brawn Biotech | -4.69 | -2.19 | 12.35 | 23.75 | -16.07 | 0.95 | 0.11 |
| Sun Pharmaceutical Industries | 0.17 | 3.74 | 6.68 | -4.16 | -6.55 | 18.09 | 27.12 |
| Divi's Laboratories | -1.33 | 8.72 | 12.62 | 11.72 | 12.1 | 24.93 | 14.22 |
| Cipla | 0.19 | 0.65 | 1.28 | 1.19 | -5.48 | 9.97 | 14.56 |
| Torrent Pharmaceuticals | 0.45 | 0.22 | 0.08 | 12.32 | 11.9 | 28.64 | 22.91 |
| Dr. Reddy's Laboratories | 0.63 | -2.36 | -0.52 | 4.93 | -5.97 | 10.34 | 4.32 |
| Zydus Lifesciences | -3.15 | -4.29 | 0.89 | 8.25 | -2.57 | 27.92 | 16.65 |
| Mankind Pharma | -5 | -7.62 | -8.22 | -7.02 | -14.88 | 16.7 | 9.71 |
| Lupin | 0.34 | 3.42 | 2.82 | -2.13 | -6.34 | 40.55 | 16.52 |
| Alkem Laboratories | 3.04 | 3.32 | 19.11 | 14.89 | -0.47 | 20.74 | 15.42 |
| Aurobindo Pharma | -1.38 | 4.96 | 7.8 | -3.05 | -15.41 | 26.32 | 7.37 |
| Abbott India | -0.61 | -3.46 | -12.18 | -3.99 | 0.88 | 14.26 | 13.16 |
| Laurus Labs | 3.06 | 14.62 | 19.81 | 67.88 | 97.14 | 28.45 | 30.06 |
| Glenmark Pharmaceuticals | -3.46 | -5.22 | -9.58 | 28.9 | 9.58 | 62.8 | 30.55 |
| Biocon | 2.19 | 9.02 | 10.72 | 13.61 | 18.33 | 10.97 | -1.75 |
| GlaxoSmithKline Pharmaceuticals | -1.28 | -5.03 | -2.19 | -5.49 | 1.39 | 24.59 | 12.94 |
| Anthem Biosciences | -1.65 | -9.28 | -4.31 | -4.34 | -4.34 | -1.47 | -0.88 |
| Ipca Laboratories | 3.32 | -2.94 | -5.07 | -2.66 | -15.56 | 13.23 | 3.03 |
| Ajanta Pharma | 2.5 | 4.86 | -2.95 | 0.31 | -11.87 | 26.54 | 19.21 |
| Gland Pharma | -3.34 | -4.65 | -3.52 | 31.94 | 4.72 | 1.03 | 0.48 |
Over the last one year, Brawn Biotech has declined 16.07% compared to peers like Sun Pharmaceutical Industries (-6.55%), Divi's Laboratories (12.10%), Cipla (-5.48%). From a 5 year perspective, Brawn Biotech has underperformed peers relative to Sun Pharmaceutical Industries (27.12%) and Divi's Laboratories (14.22%).
Brawn Biotech Financials
Brawn Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 20.83 | 20.71 |
| 10 | 20.39 | 20.69 |
| 20 | 21.02 | 20.77 |
| 50 | 21.09 | 20.57 |
| 100 | 19.44 | 20 |
| 200 | 19.32 | 19.68 |
Brawn Biotech Share Holding Pattern
In the latest quarter, Brawn Biotech remained same as its previous close in promoter holding, while DII stake unchanged at 0.35%, FII holding unchanged at 0.00%, and public shareholding moved down to 45.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Brawn Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 06, 2025, 10:39 PM IST | Brawn Biotech - Board Meeting Intimation for Considering And Approving Inter Alia The Unaudited Financial Results For Quarter |
| Oct 14, 2025, 10:57 PM IST | Brawn Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 11:44 PM IST | Brawn Biotech - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure |
| Sep 30, 2025, 11:11 PM IST | Brawn Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 30, 2025, 9:13 PM IST | Brawn Biotech - Shareholder Meeting / Postal Ballot-Outcome of AGM |
About Brawn Biotech
Brawn Biotech Ltd. is a Public Limited Listed company incorporated on 07/11/1985 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1985PLC022468 and registration number is 022468. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 13.46 Cr. and Equity Capital is Rs. 3.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressC-64, First Floor, New Delhi Delhi 110024
- Contact
Management
- Mr. Brij Raj GuptaDirector
- Mrs. Brij Bala GuptaDirector
- Mr. Mayank JainIndependent Director
- Mrs. Pooja JhaIndependent Director
FAQs on Brawn Biotech Share Price
What is the share price of Brawn Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brawn Biotech is ₹20.11 as on Nov 04, 2025.
What kind of stock is Brawn Biotech?
The Brawn Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Brawn Biotech?
The market cap of Brawn Biotech is ₹6.03 Cr as on Nov 04, 2025.
What are today's High and Low prices of Brawn Biotech?
Today’s highest and lowest price of Brawn Biotech are ₹20.11 and ₹20.11.
What are the 52 Week High and 52 Week Low of Brawn Biotech?
The 52-week high/low is the highest and lowest price at which Brawn Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Brawn Biotech is ₹26.05 and 52-week low of Brawn Biotech is ₹15.46 as on Nov 04, 2025.
How has the Brawn Biotech performed historically in terms of returns?
The Brawn Biotech has shown returns of -4.69% over the past day, -5.94% for the past month, 6.85% over 3 months, -10.86% over 1 year, 0.95% across 3 years, and 0.11% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Brawn Biotech?
P/E ratio of and PB ratio of Brawn Biotech are -5.84 and 1.79 on Nov 04, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse